Form 4 holding
Director
Tarsus Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 2,417
- Estimated value
- $177,751
- Report date
- 25 Jun 2026
- Price
- $26.53
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount